A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
Status:
Terminated
Trial end date:
2012-08-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and tolerability of otelixizumab in
patients with Graves' ophthalmopathy (thyroid eye disease). There is currently no alternative
therapy available for this condition other than treatment with steroids, or radiotherapy and
surgery. The study also includes a comparison of the current steroid treatment,
methylprednisolone, with the proposed new otelixizumab treatment.